Here are some answers to frequently asked questions about
clinical trials at Duke.
Who sponsors clinical research?
Clinical trials may be funded by the federal government
(through the National Institutes of Health or other
organizations), physicians, medical centers, foundations, or
pharmaceutical companies.
Trials normally take place at Duke University Medical
Center. Patients usually receive free or subsidized care for
the duration of the trial, but sometimes participants are
required to pay for treatment or tests. Insurance may or may
not cover care received during a clinical trial.
What are the risks of participation?
It is important to realize that there are some risks to
participating in a clinical trial. They may include:
- Unpleasant or even serious side effects
- Ineffective, experimental treatment
- Inconvenience resulting from trips to the study site,
hospital stays, complex dosage requirements, etc.
How is my safety protected?
Trial practitioners must abide by the same ethical and legal
codes they follow during routine care. Certain federal
regulations also apply specifically to clinical research.
The process starts with a study protocol, which is a plan
that must meet certain safety standards to be approved by
Duke’s Institutional Review Board (IRB). Our IRB often requires
researchers to report back periodically throughout the course
of the trial to ensure patient safety.
The IRB also carefully reviews the consent form for the
study to ensure that it meets all the criteria of the federal
regulations that govern clinical trials.
When researchers publish the results of the trial, individuals’
names are kept secret to maintain patient privacy.
What
is informed consent?
Informed consent is the process of learning key information
about a clinical trial before deciding whether to participate.
The informed consent process involves talking to a doctor,
nurse, or other researcher about the trial and reviewing the
consent form document with him or her.
During the consent process, you will learn about the study’s
purpose, the activities you will undergo, how long you will be
in the study, any potential benefits or risks (bad effects) you
may experience as a result of the study, and other aspects of
the study.
In addition, you will be encouraged to ask any questions you
may have about the study. If you decide to participate after
going through the consent process, then you will be asked to
sign the consent form.
Can a participant leave a trial once it has begun?
As a research participant, you have the right to withdraw
from a study at any time. You can withdraw, or decide not to
participate at all, without affecting your access to health
care at Duke.
What happens when a clinical trial is over?
After a clinical trial has come to a conclusion, researchers
analyze the results to determine what they mean. After a phase
I or II trial, they need to decide whether to advance to the
next phase or discontinue testing.
After a study has completed phase III, researchers assess
the medical importance of the data and publish the results in a
scientific journal. If the results show that the new treatment
or drug is safe and effective, it may become standard practice
in medical centers across the country.
Where can I learn more about what to consider before
volunteering to be in a clinical trial?
Becoming a Research Volunteer: It's Your
Decision - OHRP
Folleto:
Ser Voluntario en Estudios Clinicos: Es Su
Decisión
Basic
Questions and Answers about Clinical Trials - FDA
Why
Volunteer? Clinical Trials of Medical Treatments - FDA
(PDF
version 339KB)
Educational
Materials About Clinical Trials - National Cancer
Institute
Who can I call to discuss problems, concerns, and questions
or to obtain information or offer input?
The Institutional Review Board Office at 919-668-5111 can be
contacted to discuss problems, concerns and questions or to
obtain information or offer input.
Learn More
Click a link to find out more about clinical trials at
Duke.